Biocorrx Inc New (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 215 | -151 | 635 | 178 | 135 |
| Cost of Goods | 25 | -337 | 359 | N/A | N/A |
| Gross Profit | 189 | 186 | 276 | 178 | 135 |
| Operating Expenses | 1,158 | 383 | 2,581 | 1,592 | 1,073 |
| Operating Income | -956 | -534 | -1,946 | -1,414 | -938 |
| Interest Expense | 167 | 188 | 225 | 201 | 248 |
| Other Income | 263 | 251 | 1,362 | 238 | 334 |
| Pre-tax Income | -860 | -471 | -809 | -1,377 | -852 |
| Net Income Continuous | -860 | -471 | -809 | -1,377 | -852 |
| Minority Interests | -29 | -1,024 | 1,109 | -144 | -10 |
| Net Income | $-831 | $553 | $-1,918 | $-1,233 | $-841 |
| EPS Basic Total Ops | -0.03 | 0.05 | -0.11 | -0.07 | -0.06 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.04 | -0.08 | -0.06 |
| EPS Diluted Total Ops | -0.03 | 0.05 | -0.11 | -0.07 | -0.06 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.04 | -0.08 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.03 | 0.05 | -0.11 | -0.07 | -0.06 |
| EBITDA(a) | $-806 | $-525 | $-1,740 | $-1,212 | $-737 |